Medical Devices & Consumables
Global Disposable Serological Pipette Market Outlook, In‑Depth Analysis & Forecast to 2031
- Nov 18, 25
- ID: 607091
- Pages: 175
- Figures: 176
- Views: 4
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Disposable Serological Pipette market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Thermo Fisher Scientific
Corning
VWR
Sarstedt
Merck
Eppendorf
Argos Technologies
CAPP
Camlab
HiMedia Laboratories
TPP
Greiner Bio-One
Biofil
NEST
Sorfa
CITOTEST
Vazyme
Segment by Type
1ml
2ml
5ml
10ml
Other
Segment by Application
Pharmaceutical Factory
Medical Institutions
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Disposable Serological Pipette study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Disposable Serological Pipette market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region's dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Thermo Fisher Scientific
Corning
VWR
Sarstedt
Merck
Eppendorf
Argos Technologies
CAPP
Camlab
HiMedia Laboratories
TPP
Greiner Bio-One
Biofil
NEST
Sorfa
CITOTEST
Vazyme
Segment by Type
1ml
2ml
5ml
10ml
Other
Segment by Application
Pharmaceutical Factory
Medical Institutions
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Disposable Serological Pipette study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
1 Study Coverage
1.1 Introduction to Disposable Serological Pipette: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Disposable Serological Pipette Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1ml
1.2.3 2ml
1.2.4 5ml
1.2.5 10ml
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Disposable Serological Pipette Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Factory
1.3.3 Medical Institutions
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Disposable Serological Pipette Revenue Estimates and Forecasts 2020-2031
2.2 Global Disposable Serological Pipette Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Disposable Serological Pipette Sales Estimates and Forecasts 2020-2031
2.4 Global Disposable Serological Pipette Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Disposable Serological Pipette Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Disposable Serological Pipette Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1ml Market Size by Manufacturers
3.5.2 2ml Market Size by Manufacturers
3.5.3 5ml Market Size by Manufacturers
3.5.4 10ml Market Size by Manufacturers
3.5.5 Other Market Size by Manufacturers
3.6 Global Disposable Serological Pipette Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Disposable Serological Pipette Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Disposable Serological Pipette Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Disposable Serological Pipette Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Disposable Serological Pipette Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
6.4 North America Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Disposable Serological Pipette Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
7.4 Europe Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Disposable Serological Pipette Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Disposable Serological Pipette Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
9.4 Central and South America Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Disposable Serological Pipette Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Disposable Serological Pipette Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Disposable Serological Pipette Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher Scientific Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Disposable Serological Pipette Sales by Product in 2024
11.1.6 Thermo Fisher Scientific Disposable Serological Pipette Sales by Application in 2024
11.1.7 Thermo Fisher Scientific Disposable Serological Pipette Sales by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Disposable Serological Pipette SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Corning
11.2.1 Corning Corporation Information
11.2.2 Corning Business Overview
11.2.3 Corning Disposable Serological Pipette Product Models, Descriptions and Specifications
11.2.4 Corning Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Corning Disposable Serological Pipette Sales by Product in 2024
11.2.6 Corning Disposable Serological Pipette Sales by Application in 2024
11.2.7 Corning Disposable Serological Pipette Sales by Geographic Area in 2024
11.2.8 Corning Disposable Serological Pipette SWOT Analysis
11.2.9 Corning Recent Developments
11.3 VWR
11.3.1 VWR Corporation Information
11.3.2 VWR Business Overview
11.3.3 VWR Disposable Serological Pipette Product Models, Descriptions and Specifications
11.3.4 VWR Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 VWR Disposable Serological Pipette Sales by Product in 2024
11.3.6 VWR Disposable Serological Pipette Sales by Application in 2024
11.3.7 VWR Disposable Serological Pipette Sales by Geographic Area in 2024
11.3.8 VWR Disposable Serological Pipette SWOT Analysis
11.3.9 VWR Recent Developments
11.4 Sarstedt
11.4.1 Sarstedt Corporation Information
11.4.2 Sarstedt Business Overview
11.4.3 Sarstedt Disposable Serological Pipette Product Models, Descriptions and Specifications
11.4.4 Sarstedt Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sarstedt Disposable Serological Pipette Sales by Product in 2024
11.4.6 Sarstedt Disposable Serological Pipette Sales by Application in 2024
11.4.7 Sarstedt Disposable Serological Pipette Sales by Geographic Area in 2024
11.4.8 Sarstedt Disposable Serological Pipette SWOT Analysis
11.4.9 Sarstedt Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Business Overview
11.5.3 Merck Disposable Serological Pipette Product Models, Descriptions and Specifications
11.5.4 Merck Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Merck Disposable Serological Pipette Sales by Product in 2024
11.5.6 Merck Disposable Serological Pipette Sales by Application in 2024
11.5.7 Merck Disposable Serological Pipette Sales by Geographic Area in 2024
11.5.8 Merck Disposable Serological Pipette SWOT Analysis
11.5.9 Merck Recent Developments
11.6 Eppendorf
11.6.1 Eppendorf Corporation Information
11.6.2 Eppendorf Business Overview
11.6.3 Eppendorf Disposable Serological Pipette Product Models, Descriptions and Specifications
11.6.4 Eppendorf Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Eppendorf Recent Developments
11.7 Argos Technologies
11.7.1 Argos Technologies Corporation Information
11.7.2 Argos Technologies Business Overview
11.7.3 Argos Technologies Disposable Serological Pipette Product Models, Descriptions and Specifications
11.7.4 Argos Technologies Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Argos Technologies Recent Developments
11.8 CAPP
11.8.1 CAPP Corporation Information
11.8.2 CAPP Business Overview
11.8.3 CAPP Disposable Serological Pipette Product Models, Descriptions and Specifications
11.8.4 CAPP Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 CAPP Recent Developments
11.9 Camlab
11.9.1 Camlab Corporation Information
11.9.2 Camlab Business Overview
11.9.3 Camlab Disposable Serological Pipette Product Models, Descriptions and Specifications
11.9.4 Camlab Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Camlab Recent Developments
11.10 HiMedia Laboratories
11.10.1 HiMedia Laboratories Corporation Information
11.10.2 HiMedia Laboratories Business Overview
11.10.3 HiMedia Laboratories Disposable Serological Pipette Product Models, Descriptions and Specifications
11.10.4 HiMedia Laboratories Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 HiMedia Laboratories Recent Developments
11.11 TPP
11.11.1 TPP Corporation Information
11.11.2 TPP Business Overview
11.11.3 TPP Disposable Serological Pipette Product Models, Descriptions and Specifications
11.11.4 TPP Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 TPP Recent Developments
11.12 Greiner Bio-One
11.12.1 Greiner Bio-One Corporation Information
11.12.2 Greiner Bio-One Business Overview
11.12.3 Greiner Bio-One Disposable Serological Pipette Product Models, Descriptions and Specifications
11.12.4 Greiner Bio-One Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Greiner Bio-One Recent Developments
11.13 Biofil
11.13.1 Biofil Corporation Information
11.13.2 Biofil Business Overview
11.13.3 Biofil Disposable Serological Pipette Product Models, Descriptions and Specifications
11.13.4 Biofil Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Biofil Recent Developments
11.14 NEST
11.14.1 NEST Corporation Information
11.14.2 NEST Business Overview
11.14.3 NEST Disposable Serological Pipette Product Models, Descriptions and Specifications
11.14.4 NEST Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NEST Recent Developments
11.15 Sorfa
11.15.1 Sorfa Corporation Information
11.15.2 Sorfa Business Overview
11.15.3 Sorfa Disposable Serological Pipette Product Models, Descriptions and Specifications
11.15.4 Sorfa Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Sorfa Recent Developments
11.16 CITOTEST
11.16.1 CITOTEST Corporation Information
11.16.2 CITOTEST Business Overview
11.16.3 CITOTEST Disposable Serological Pipette Product Models, Descriptions and Specifications
11.16.4 CITOTEST Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 CITOTEST Recent Developments
11.17 Vazyme
11.17.1 Vazyme Corporation Information
11.17.2 Vazyme Business Overview
11.17.3 Vazyme Disposable Serological Pipette Product Models, Descriptions and Specifications
11.17.4 Vazyme Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Vazyme Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Disposable Serological Pipette Industry Chain
12.2 Disposable Serological Pipette Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Disposable Serological Pipette Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Disposable Serological Pipette Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Disposable Serological Pipette Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Disposable Serological Pipette Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
1.1 Introduction to Disposable Serological Pipette: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Disposable Serological Pipette Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1ml
1.2.3 2ml
1.2.4 5ml
1.2.5 10ml
1.2.6 Other
1.3 Market Segmentation by Application
1.3.1 Global Disposable Serological Pipette Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Factory
1.3.3 Medical Institutions
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Disposable Serological Pipette Revenue Estimates and Forecasts 2020-2031
2.2 Global Disposable Serological Pipette Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Disposable Serological Pipette Sales Estimates and Forecasts 2020-2031
2.4 Global Disposable Serological Pipette Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Disposable Serological Pipette Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Disposable Serological Pipette Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1ml Market Size by Manufacturers
3.5.2 2ml Market Size by Manufacturers
3.5.3 5ml Market Size by Manufacturers
3.5.4 10ml Market Size by Manufacturers
3.5.5 Other Market Size by Manufacturers
3.6 Global Disposable Serological Pipette Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Disposable Serological Pipette Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Disposable Serological Pipette Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Disposable Serological Pipette Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Disposable Serological Pipette Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
6.4 North America Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Disposable Serological Pipette Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
7.4 Europe Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Disposable Serological Pipette Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Disposable Serological Pipette Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
9.4 Central and South America Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Disposable Serological Pipette Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Disposable Serological Pipette Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Disposable Serological Pipette Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Disposable Serological Pipette Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Disposable Serological Pipette Product Models, Descriptions and Specifications
11.1.4 Thermo Fisher Scientific Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Disposable Serological Pipette Sales by Product in 2024
11.1.6 Thermo Fisher Scientific Disposable Serological Pipette Sales by Application in 2024
11.1.7 Thermo Fisher Scientific Disposable Serological Pipette Sales by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Disposable Serological Pipette SWOT Analysis
11.1.9 Thermo Fisher Scientific Recent Developments
11.2 Corning
11.2.1 Corning Corporation Information
11.2.2 Corning Business Overview
11.2.3 Corning Disposable Serological Pipette Product Models, Descriptions and Specifications
11.2.4 Corning Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Corning Disposable Serological Pipette Sales by Product in 2024
11.2.6 Corning Disposable Serological Pipette Sales by Application in 2024
11.2.7 Corning Disposable Serological Pipette Sales by Geographic Area in 2024
11.2.8 Corning Disposable Serological Pipette SWOT Analysis
11.2.9 Corning Recent Developments
11.3 VWR
11.3.1 VWR Corporation Information
11.3.2 VWR Business Overview
11.3.3 VWR Disposable Serological Pipette Product Models, Descriptions and Specifications
11.3.4 VWR Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 VWR Disposable Serological Pipette Sales by Product in 2024
11.3.6 VWR Disposable Serological Pipette Sales by Application in 2024
11.3.7 VWR Disposable Serological Pipette Sales by Geographic Area in 2024
11.3.8 VWR Disposable Serological Pipette SWOT Analysis
11.3.9 VWR Recent Developments
11.4 Sarstedt
11.4.1 Sarstedt Corporation Information
11.4.2 Sarstedt Business Overview
11.4.3 Sarstedt Disposable Serological Pipette Product Models, Descriptions and Specifications
11.4.4 Sarstedt Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Sarstedt Disposable Serological Pipette Sales by Product in 2024
11.4.6 Sarstedt Disposable Serological Pipette Sales by Application in 2024
11.4.7 Sarstedt Disposable Serological Pipette Sales by Geographic Area in 2024
11.4.8 Sarstedt Disposable Serological Pipette SWOT Analysis
11.4.9 Sarstedt Recent Developments
11.5 Merck
11.5.1 Merck Corporation Information
11.5.2 Merck Business Overview
11.5.3 Merck Disposable Serological Pipette Product Models, Descriptions and Specifications
11.5.4 Merck Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Merck Disposable Serological Pipette Sales by Product in 2024
11.5.6 Merck Disposable Serological Pipette Sales by Application in 2024
11.5.7 Merck Disposable Serological Pipette Sales by Geographic Area in 2024
11.5.8 Merck Disposable Serological Pipette SWOT Analysis
11.5.9 Merck Recent Developments
11.6 Eppendorf
11.6.1 Eppendorf Corporation Information
11.6.2 Eppendorf Business Overview
11.6.3 Eppendorf Disposable Serological Pipette Product Models, Descriptions and Specifications
11.6.4 Eppendorf Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Eppendorf Recent Developments
11.7 Argos Technologies
11.7.1 Argos Technologies Corporation Information
11.7.2 Argos Technologies Business Overview
11.7.3 Argos Technologies Disposable Serological Pipette Product Models, Descriptions and Specifications
11.7.4 Argos Technologies Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Argos Technologies Recent Developments
11.8 CAPP
11.8.1 CAPP Corporation Information
11.8.2 CAPP Business Overview
11.8.3 CAPP Disposable Serological Pipette Product Models, Descriptions and Specifications
11.8.4 CAPP Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 CAPP Recent Developments
11.9 Camlab
11.9.1 Camlab Corporation Information
11.9.2 Camlab Business Overview
11.9.3 Camlab Disposable Serological Pipette Product Models, Descriptions and Specifications
11.9.4 Camlab Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Camlab Recent Developments
11.10 HiMedia Laboratories
11.10.1 HiMedia Laboratories Corporation Information
11.10.2 HiMedia Laboratories Business Overview
11.10.3 HiMedia Laboratories Disposable Serological Pipette Product Models, Descriptions and Specifications
11.10.4 HiMedia Laboratories Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 HiMedia Laboratories Recent Developments
11.11 TPP
11.11.1 TPP Corporation Information
11.11.2 TPP Business Overview
11.11.3 TPP Disposable Serological Pipette Product Models, Descriptions and Specifications
11.11.4 TPP Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 TPP Recent Developments
11.12 Greiner Bio-One
11.12.1 Greiner Bio-One Corporation Information
11.12.2 Greiner Bio-One Business Overview
11.12.3 Greiner Bio-One Disposable Serological Pipette Product Models, Descriptions and Specifications
11.12.4 Greiner Bio-One Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Greiner Bio-One Recent Developments
11.13 Biofil
11.13.1 Biofil Corporation Information
11.13.2 Biofil Business Overview
11.13.3 Biofil Disposable Serological Pipette Product Models, Descriptions and Specifications
11.13.4 Biofil Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Biofil Recent Developments
11.14 NEST
11.14.1 NEST Corporation Information
11.14.2 NEST Business Overview
11.14.3 NEST Disposable Serological Pipette Product Models, Descriptions and Specifications
11.14.4 NEST Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 NEST Recent Developments
11.15 Sorfa
11.15.1 Sorfa Corporation Information
11.15.2 Sorfa Business Overview
11.15.3 Sorfa Disposable Serological Pipette Product Models, Descriptions and Specifications
11.15.4 Sorfa Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 Sorfa Recent Developments
11.16 CITOTEST
11.16.1 CITOTEST Corporation Information
11.16.2 CITOTEST Business Overview
11.16.3 CITOTEST Disposable Serological Pipette Product Models, Descriptions and Specifications
11.16.4 CITOTEST Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 CITOTEST Recent Developments
11.17 Vazyme
11.17.1 Vazyme Corporation Information
11.17.2 Vazyme Business Overview
11.17.3 Vazyme Disposable Serological Pipette Product Models, Descriptions and Specifications
11.17.4 Vazyme Disposable Serological Pipette Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Vazyme Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Disposable Serological Pipette Industry Chain
12.2 Disposable Serological Pipette Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Disposable Serological Pipette Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Disposable Serological Pipette Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Disposable Serological Pipette Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Disposable Serological Pipette Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Disposable Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Disposable Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Disposable Serological Pipette Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Disposable Serological Pipette Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Disposable Serological Pipette Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Disposable Serological Pipette Sales by Region (2020-2025) & (K Units)
Table 8. Global Disposable Serological Pipette Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Disposable Serological Pipette Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Disposable Serological Pipette Sales Share by Manufacturers (2020-2025)
Table 12. Global Disposable Serological Pipette Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Disposable Serological Pipette Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Disposable Serological Pipette by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disposable Serological Pipette as of 2024)
Table 16. Global Disposable Serological Pipette Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Disposable Serological Pipette Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Disposable Serological Pipette Manufacturing Base and Headquarters
Table 19. Global Disposable Serological Pipette Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Disposable Serological Pipette Sales by Type (2020-2025) & (K Units)
Table 23. Global Disposable Serological Pipette Sales by Type (2026-2031) & (K Units)
Table 24. Global Disposable Serological Pipette Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Disposable Serological Pipette Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Disposable Serological Pipette ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Disposable Serological Pipette Sales by Application (2020-2025) & (K Units)
Table 29. Global Disposable Serological Pipette Sales by Application (2026-2031) & (K Units)
Table 30. Disposable Serological Pipette High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Disposable Serological Pipette Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Disposable Serological Pipette Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Disposable Serological Pipette ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 37. North America Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 40. Europe Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 45. Southeast Asia Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Disposable Serological Pipette Investment Opportunities and Key Challenges
Table 47. Central and South America Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Disposable Serological Pipette Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Scientific Corporation Information
Table 51. Thermo Fisher Scientific Description and Major Businesses
Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher Scientific Disposable Serological Pipette SWOT Analysis
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Corning Corporation Information
Table 60. Corning Description and Major Businesses
Table 61. Corning Product Models, Descriptions and Specifications
Table 62. Corning Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Corning Sales Value Proportion by Product in 2024
Table 64. Corning Sales Value Proportion by Application in 2024
Table 65. Corning Sales Value Proportion by Geographic Area in 2024
Table 66. Corning Disposable Serological Pipette SWOT Analysis
Table 67. Corning Recent Developments
Table 68. VWR Corporation Information
Table 69. VWR Description and Major Businesses
Table 70. VWR Product Models, Descriptions and Specifications
Table 71. VWR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. VWR Sales Value Proportion by Product in 2024
Table 73. VWR Sales Value Proportion by Application in 2024
Table 74. VWR Sales Value Proportion by Geographic Area in 2024
Table 75. VWR Disposable Serological Pipette SWOT Analysis
Table 76. VWR Recent Developments
Table 77. Sarstedt Corporation Information
Table 78. Sarstedt Description and Major Businesses
Table 79. Sarstedt Product Models, Descriptions and Specifications
Table 80. Sarstedt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sarstedt Sales Value Proportion by Product in 2024
Table 82. Sarstedt Sales Value Proportion by Application in 2024
Table 83. Sarstedt Sales Value Proportion by Geographic Area in 2024
Table 84. Sarstedt Disposable Serological Pipette SWOT Analysis
Table 85. Sarstedt Recent Developments
Table 86. Merck Corporation Information
Table 87. Merck Description and Major Businesses
Table 88. Merck Product Models, Descriptions and Specifications
Table 89. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Merck Sales Value Proportion by Product in 2024
Table 91. Merck Sales Value Proportion by Application in 2024
Table 92. Merck Sales Value Proportion by Geographic Area in 2024
Table 93. Merck Disposable Serological Pipette SWOT Analysis
Table 94. Merck Recent Developments
Table 95. Eppendorf Corporation Information
Table 96. Eppendorf Description and Major Businesses
Table 97. Eppendorf Product Models, Descriptions and Specifications
Table 98. Eppendorf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Eppendorf Recent Developments
Table 100. Argos Technologies Corporation Information
Table 101. Argos Technologies Description and Major Businesses
Table 102. Argos Technologies Product Models, Descriptions and Specifications
Table 103. Argos Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Argos Technologies Recent Developments
Table 105. CAPP Corporation Information
Table 106. CAPP Description and Major Businesses
Table 107. CAPP Product Models, Descriptions and Specifications
Table 108. CAPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. CAPP Recent Developments
Table 110. Camlab Corporation Information
Table 111. Camlab Description and Major Businesses
Table 112. Camlab Product Models, Descriptions and Specifications
Table 113. Camlab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Camlab Recent Developments
Table 115. HiMedia Laboratories Corporation Information
Table 116. HiMedia Laboratories Description and Major Businesses
Table 117. HiMedia Laboratories Product Models, Descriptions and Specifications
Table 118. HiMedia Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. HiMedia Laboratories Recent Developments
Table 120. TPP Corporation Information
Table 121. TPP Description and Major Businesses
Table 122. TPP Product Models, Descriptions and Specifications
Table 123. TPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. TPP Recent Developments
Table 125. Greiner Bio-One Corporation Information
Table 126. Greiner Bio-One Description and Major Businesses
Table 127. Greiner Bio-One Product Models, Descriptions and Specifications
Table 128. Greiner Bio-One Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Greiner Bio-One Recent Developments
Table 130. Biofil Corporation Information
Table 131. Biofil Description and Major Businesses
Table 132. Biofil Product Models, Descriptions and Specifications
Table 133. Biofil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biofil Recent Developments
Table 135. NEST Corporation Information
Table 136. NEST Description and Major Businesses
Table 137. NEST Product Models, Descriptions and Specifications
Table 138. NEST Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. NEST Recent Developments
Table 140. Sorfa Corporation Information
Table 141. Sorfa Description and Major Businesses
Table 142. Sorfa Product Models, Descriptions and Specifications
Table 143. Sorfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Sorfa Recent Developments
Table 145. CITOTEST Corporation Information
Table 146. CITOTEST Description and Major Businesses
Table 147. CITOTEST Product Models, Descriptions and Specifications
Table 148. CITOTEST Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. CITOTEST Recent Developments
Table 150. Vazyme Corporation Information
Table 151. Vazyme Description and Major Businesses
Table 152. Vazyme Product Models, Descriptions and Specifications
Table 153. Vazyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Vazyme Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Disposable Serological Pipette Product Picture
Figure 2. Global Disposable Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 1ml Product Picture
Figure 4. 2ml Product Picture
Figure 5. 5ml Product Picture
Figure 6. 10ml Product Picture
Figure 7. Other Product Picture
Figure 8. Global Disposable Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Pharmaceutical Factory
Figure 10. Medical Institutions
Figure 11. Other
Figure 12. Disposable Serological Pipette Report Years Considered
Figure 13. Global Disposable Serological Pipette Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 15. Global Disposable Serological Pipette Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Disposable Serological Pipette Revenue Market Share by Region (2020-2031)
Figure 17. Global Disposable Serological Pipette Sales (2020-2031) & (K Units)
Figure 18. Global Disposable Serological Pipette Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Disposable Serological Pipette Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Disposable Serological Pipette Sales Volume Market Share in 2024
Figure 21. Global Disposable Serological Pipette Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 1ml Revenue Market Share by Manufacturer in 2024
Figure 24. 2ml Revenue Market Share by Manufacturer in 2024
Figure 25. 5ml Revenue Market Share by Manufacturer in 2024
Figure 26. 10ml Revenue Market Share by Manufacturer in 2024
Figure 27. Other Revenue Market Share by Manufacturer in 2024
Figure 28. Global Disposable Serological Pipette Sales Market Share by Type (2020-2031)
Figure 29. Global Disposable Serological Pipette Revenue Market Share by Type (2020-2031)
Figure 30. Global Disposable Serological Pipette Sales Market Share by Application (2020-2031)
Figure 31. Global Disposable Serological Pipette Revenue Market Share by Application (2020-2031)
Figure 32. North America Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 33. North America Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 35. North America Disposable Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 36. North America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 38. North America Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 43. Europe Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 45. Europe Disposable Serological Pipette Sales Volume (K Units) by Type (2020-2031)
Figure 46. Europe Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 48. Europe Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 50. France Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 55. Asia-Pacific Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Disposable Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 58. Asia-Pacific Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 60. Asia-Pacific Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 65. India Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 67. Central and South America Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Disposable Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 70. Central and South America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 72. Central and South America Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 76. Middle East and Africa Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Disposable Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 79. South America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 81. Middle East and Africa Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 86. Disposable Serological Pipette Industry Chain Mapping
Figure 87. Regional Disposable Serological Pipette Manufacturing Base Distribution (%)
Figure 88. Global Disposable Serological Pipette Production Market Share by Region (2020-2031)
Figure 89. Disposable Serological Pipette Production Process
Figure 90. Regional Disposable Serological Pipette Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Table 1. Global Disposable Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Disposable Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Disposable Serological Pipette Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Disposable Serological Pipette Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Disposable Serological Pipette Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global Disposable Serological Pipette Sales by Region (2020-2025) & (K Units)
Table 8. Global Disposable Serological Pipette Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Disposable Serological Pipette Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global Disposable Serological Pipette Sales Share by Manufacturers (2020-2025)
Table 12. Global Disposable Serological Pipette Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Disposable Serological Pipette Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Disposable Serological Pipette by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Disposable Serological Pipette as of 2024)
Table 16. Global Disposable Serological Pipette Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Disposable Serological Pipette Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers Disposable Serological Pipette Manufacturing Base and Headquarters
Table 19. Global Disposable Serological Pipette Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Disposable Serological Pipette Sales by Type (2020-2025) & (K Units)
Table 23. Global Disposable Serological Pipette Sales by Type (2026-2031) & (K Units)
Table 24. Global Disposable Serological Pipette Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Disposable Serological Pipette Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Disposable Serological Pipette ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Disposable Serological Pipette Sales by Application (2020-2025) & (K Units)
Table 29. Global Disposable Serological Pipette Sales by Application (2026-2031) & (K Units)
Table 30. Disposable Serological Pipette High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Disposable Serological Pipette Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Disposable Serological Pipette Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Disposable Serological Pipette ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 37. North America Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 40. Europe Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Disposable Serological Pipette Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Disposable Serological Pipette Growth Accelerators and Market Barriers
Table 45. Southeast Asia Disposable Serological Pipette Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Disposable Serological Pipette Investment Opportunities and Key Challenges
Table 47. Central and South America Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Disposable Serological Pipette Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Disposable Serological Pipette Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Thermo Fisher Scientific Corporation Information
Table 51. Thermo Fisher Scientific Description and Major Businesses
Table 52. Thermo Fisher Scientific Product Models, Descriptions and Specifications
Table 53. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Thermo Fisher Scientific Sales Value Proportion by Product in 2024
Table 55. Thermo Fisher Scientific Sales Value Proportion by Application in 2024
Table 56. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024
Table 57. Thermo Fisher Scientific Disposable Serological Pipette SWOT Analysis
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Corning Corporation Information
Table 60. Corning Description and Major Businesses
Table 61. Corning Product Models, Descriptions and Specifications
Table 62. Corning Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Corning Sales Value Proportion by Product in 2024
Table 64. Corning Sales Value Proportion by Application in 2024
Table 65. Corning Sales Value Proportion by Geographic Area in 2024
Table 66. Corning Disposable Serological Pipette SWOT Analysis
Table 67. Corning Recent Developments
Table 68. VWR Corporation Information
Table 69. VWR Description and Major Businesses
Table 70. VWR Product Models, Descriptions and Specifications
Table 71. VWR Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. VWR Sales Value Proportion by Product in 2024
Table 73. VWR Sales Value Proportion by Application in 2024
Table 74. VWR Sales Value Proportion by Geographic Area in 2024
Table 75. VWR Disposable Serological Pipette SWOT Analysis
Table 76. VWR Recent Developments
Table 77. Sarstedt Corporation Information
Table 78. Sarstedt Description and Major Businesses
Table 79. Sarstedt Product Models, Descriptions and Specifications
Table 80. Sarstedt Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Sarstedt Sales Value Proportion by Product in 2024
Table 82. Sarstedt Sales Value Proportion by Application in 2024
Table 83. Sarstedt Sales Value Proportion by Geographic Area in 2024
Table 84. Sarstedt Disposable Serological Pipette SWOT Analysis
Table 85. Sarstedt Recent Developments
Table 86. Merck Corporation Information
Table 87. Merck Description and Major Businesses
Table 88. Merck Product Models, Descriptions and Specifications
Table 89. Merck Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. Merck Sales Value Proportion by Product in 2024
Table 91. Merck Sales Value Proportion by Application in 2024
Table 92. Merck Sales Value Proportion by Geographic Area in 2024
Table 93. Merck Disposable Serological Pipette SWOT Analysis
Table 94. Merck Recent Developments
Table 95. Eppendorf Corporation Information
Table 96. Eppendorf Description and Major Businesses
Table 97. Eppendorf Product Models, Descriptions and Specifications
Table 98. Eppendorf Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 99. Eppendorf Recent Developments
Table 100. Argos Technologies Corporation Information
Table 101. Argos Technologies Description and Major Businesses
Table 102. Argos Technologies Product Models, Descriptions and Specifications
Table 103. Argos Technologies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. Argos Technologies Recent Developments
Table 105. CAPP Corporation Information
Table 106. CAPP Description and Major Businesses
Table 107. CAPP Product Models, Descriptions and Specifications
Table 108. CAPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 109. CAPP Recent Developments
Table 110. Camlab Corporation Information
Table 111. Camlab Description and Major Businesses
Table 112. Camlab Product Models, Descriptions and Specifications
Table 113. Camlab Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 114. Camlab Recent Developments
Table 115. HiMedia Laboratories Corporation Information
Table 116. HiMedia Laboratories Description and Major Businesses
Table 117. HiMedia Laboratories Product Models, Descriptions and Specifications
Table 118. HiMedia Laboratories Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 119. HiMedia Laboratories Recent Developments
Table 120. TPP Corporation Information
Table 121. TPP Description and Major Businesses
Table 122. TPP Product Models, Descriptions and Specifications
Table 123. TPP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 124. TPP Recent Developments
Table 125. Greiner Bio-One Corporation Information
Table 126. Greiner Bio-One Description and Major Businesses
Table 127. Greiner Bio-One Product Models, Descriptions and Specifications
Table 128. Greiner Bio-One Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 129. Greiner Bio-One Recent Developments
Table 130. Biofil Corporation Information
Table 131. Biofil Description and Major Businesses
Table 132. Biofil Product Models, Descriptions and Specifications
Table 133. Biofil Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 134. Biofil Recent Developments
Table 135. NEST Corporation Information
Table 136. NEST Description and Major Businesses
Table 137. NEST Product Models, Descriptions and Specifications
Table 138. NEST Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 139. NEST Recent Developments
Table 140. Sorfa Corporation Information
Table 141. Sorfa Description and Major Businesses
Table 142. Sorfa Product Models, Descriptions and Specifications
Table 143. Sorfa Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 144. Sorfa Recent Developments
Table 145. CITOTEST Corporation Information
Table 146. CITOTEST Description and Major Businesses
Table 147. CITOTEST Product Models, Descriptions and Specifications
Table 148. CITOTEST Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 149. CITOTEST Recent Developments
Table 150. Vazyme Corporation Information
Table 151. Vazyme Description and Major Businesses
Table 152. Vazyme Product Models, Descriptions and Specifications
Table 153. Vazyme Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 154. Vazyme Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Disposable Serological Pipette Product Picture
Figure 2. Global Disposable Serological Pipette Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. 1ml Product Picture
Figure 4. 2ml Product Picture
Figure 5. 5ml Product Picture
Figure 6. 10ml Product Picture
Figure 7. Other Product Picture
Figure 8. Global Disposable Serological Pipette Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Pharmaceutical Factory
Figure 10. Medical Institutions
Figure 11. Other
Figure 12. Disposable Serological Pipette Report Years Considered
Figure 13. Global Disposable Serological Pipette Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 15. Global Disposable Serological Pipette Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 16. Global Disposable Serological Pipette Revenue Market Share by Region (2020-2031)
Figure 17. Global Disposable Serological Pipette Sales (2020-2031) & (K Units)
Figure 18. Global Disposable Serological Pipette Sales (CAGR) by Region (2020-2031) (K Units)
Figure 19. Global Disposable Serological Pipette Sales Market Share by Region (2020-2031)
Figure 20. Top 5 and Top 10 Manufacturers Disposable Serological Pipette Sales Volume Market Share in 2024
Figure 21. Global Disposable Serological Pipette Revenue Market Share Ranking (2024)
Figure 22. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 23. 1ml Revenue Market Share by Manufacturer in 2024
Figure 24. 2ml Revenue Market Share by Manufacturer in 2024
Figure 25. 5ml Revenue Market Share by Manufacturer in 2024
Figure 26. 10ml Revenue Market Share by Manufacturer in 2024
Figure 27. Other Revenue Market Share by Manufacturer in 2024
Figure 28. Global Disposable Serological Pipette Sales Market Share by Type (2020-2031)
Figure 29. Global Disposable Serological Pipette Revenue Market Share by Type (2020-2031)
Figure 30. Global Disposable Serological Pipette Sales Market Share by Application (2020-2031)
Figure 31. Global Disposable Serological Pipette Revenue Market Share by Application (2020-2031)
Figure 32. North America Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 33. North America Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 34. North America Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 35. North America Disposable Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 36. North America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 37. North America Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 38. North America Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 39. US Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 40. Canada Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 41. Mexico Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 42. Europe Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 43. Europe Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 44. Europe Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 45. Europe Disposable Serological Pipette Sales Volume (K Units) by Type (2020-2031)
Figure 46. Europe Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 47. Europe Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 48. Europe Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 49. Germany Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 50. France Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 51. U.K. Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 52. Italy Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 53. Russia Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 55. Asia-Pacific Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 56. Asia-Pacific Top 8 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 57. Asia-Pacific Disposable Serological Pipette Sales Volume (K Units) by Type (2020- 2031)
Figure 58. Asia-Pacific Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 59. Asia-Pacific Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 60. Asia-Pacific Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 61. Indonesia Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 62. Japan Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 63. South Korea Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 64. China Taiwan Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 65. India Disposable Serological Pipette Revenue (2020-2031) & (US$ Million)
Figure 66. Central and South America Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 67. Central and South America Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 68. Central and South America Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 69. Central and South America Disposable Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 70. Central and South America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 71. Central and South America Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 72. Central and South America Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 73. Brazil Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 74. Argentina Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 75. Middle East, and Africa Disposable Serological Pipette Sales YoY (2020-2031) & (K Units)
Figure 76. Middle East and Africa Disposable Serological Pipette Revenue YoY (2020-2031) & (US$ Million)
Figure 77. Middle East and Africa Top 5 Manufacturers Disposable Serological Pipette Sales Revenue (US$ Million) in 2024
Figure 78. Middle East and Africa Disposable Serological Pipette Sales Volume (K Units) by Type (2021-2031)
Figure 79. South America Disposable Serological Pipette Sales Revenue (US$ Million) by Type (2020-2031)
Figure 80. Middle East and Africa Disposable Serological Pipette Sales Volume (K Units) by Application (2020-2031)
Figure 81. Middle East and Africa Disposable Serological Pipette Sales Revenue (US$ Million) by Application (2020-2031)
Figure 82. GCC Countries Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 83. Turkey Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 84. Egypt Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 85. South Africa Disposable Serological Pipette Revenue (2020-2025) & (US$ Million)
Figure 86. Disposable Serological Pipette Industry Chain Mapping
Figure 87. Regional Disposable Serological Pipette Manufacturing Base Distribution (%)
Figure 88. Global Disposable Serological Pipette Production Market Share by Region (2020-2031)
Figure 89. Disposable Serological Pipette Production Process
Figure 90. Regional Disposable Serological Pipette Production Cost Structure
Figure 91. Channels of Distribution (Direct Vs Distribution)
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Wireless Split Keyboard Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Ergonomic Adjustable Computer Chair Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Global Trackless Keyboard Tray Market Outlook, In‑Depth Analysis & Forecast to 2031
Nov 18, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232